Aytu Biopharma (AYTU) EBT (QoQ) (2011 - 2026)
Aytu Biopharma (AYTU) EBT (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.01% |
| Dec 31, 2025 | -638.63% |
| Sep 30, 2025 | 110.11% |
| Jun 30, 2025 | -609.25% |
| Mar 31, 2025 | 899.48% |
| Dec 31, 2024 | -74.50% |
| Sep 30, 2024 | 159.05% |
| Jun 30, 2024 | -43.58% |
| Mar 31, 2024 | -226.30% |
| Dec 31, 2023 | 118.72% |
| Sep 30, 2023 | -204.15% |
| Jun 30, 2023 | 65.88% |
| Mar 31, 2023 | -7.58% |
| Dec 31, 2022 | -854.78% |
| Sep 30, 2022 | 95.64% |
| Jun 30, 2022 | 69.81% |
| Mar 31, 2022 | -361.35% |
| Dec 31, 2021 | 58.68% |
| Sep 30, 2021 | -49.20% |
| Dec 31, 2020 | -121.20% |